References

  1. Dudney WC, Bodenner D, Stack Jr BC. Parathyroidcarcinoma. OtolaryngolClin North Am. 2010; 43(2):441-53. PubMed | Google Scholar

  2. Antoine Digonnet, Adelaïde Carlier, Esther Willemse et al. Parathyroid Carcinoma: A Review with Three Illustrative Cases. Journal of Cancer. 2011; 2: 532-537. PubMed | Google Scholar

  3. Kebebew E, Clark OH. Parathyroid adenoma, hyperplasia,and carcinoma: localization, technical details of primary neck exploration, and treatment of hypercalcemiccrisis. SurgOncolClinNAm. 1998;7(4):721-48. PubMed | Google Scholar

  4. Givi B, Shah JP. Parathyroid carcinoma. Clin Oncol (R CollRadiol). 2010;22(6):498-507.. PubMed | Google Scholar

  5. Sharretts JM, Simonds WF. Clinical and molecular genetics of parathyroid neoplasms. Best Pract Res Clin EndocrinolMetabol. 2010;24(3):491-502. PubMed | Google Scholar

  6. Jenkins PJ, Satta MA, Simmgen M, et al. Metastatic parathyroid carcinoma in the MEN2A syndrome. Clin Endocrinol (Oxf). 1997 Dec;47(6):747-51. PubMed | Google Scholar

  7. Avital Harari, Christina H Wei. Parathyroid carcinoma Update and Guidelines for Management. Current Treatment Options in Oncology. 2012; 13:11-23. PubMed | Google Scholar

  8. Poissonnet G et al. Le carcinome parathyroidien. Bull Cancer. 2006 ; 93 (3) : 283-7. PubMed | Google Scholar

  9. Harari A, Waring A, Fernandez-Ranvier G, et al. Para- thyroid carcinoma: a 43-year outcome and survival analysis. J ClinEndocrinolMetabol. 2011 Dec; 96(12):3679-86. PubMed | Google Scholar

  10. Gabriele Ricci et al. Parathyroid Carcinoma: The Importance of High Clinical Suspicion for a Correct Management. International Journal of Surgical Oncology. 2012; 2012:649148. PubMed | Google Scholar